IBO (Impact BioMedical) Total Stockholders Equity : $4.26 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Impact BioMedical Total Stockholders Equity?

Impact BioMedical's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $4.26 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Impact BioMedical's Book Value per Share for the quarter that ended in Dec. 2024 was $0.37. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Impact BioMedical's Debt-to-Equity for the quarter that ended in Dec. 2024 was 2.08.

Impact BioMedical Total Stockholders Equity Historical Data

The historical data trend for Impact BioMedical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Total Stockholders Equity Chart

Impact BioMedical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

37.91

36.61

29.56

25.22

4.26

Impact BioMedical Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															25.22	24.26	23.37	31.35	4.26

Impact BioMedical (AMEX:IBO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Impact BioMedical's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4.259	-	0.06)	/	11.504
	=	0.37

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Impact BioMedical's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.878	+	0)	/	4.259
	=	2.08

Impact BioMedical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Impact BioMedical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Impact BioMedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1400 Broadfield Boulevard, Suite 130, Houston, TX, USA, 77084

Website

https://www.impactbiomedinc.com

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Impact BioMedical Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024